Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ)
CNY 3.24
(1.25%)
CNY 3.24
(1.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.62 Million | 4.86 Million | 155.65 Thousand | 100.23 Million | 58.63 Million | 22.56 Million |
| Net Income | -80.41 Million | -53.28 Million | -38.27 Million | 27.65 Million | 17.49 Million | -29.71 Million |
| Depreciation & Amortization | 24.6 Million | 24.75 Million | 23.98 Million | 18.4 Million | 18.92 Million | 16.18 Million |
| Deferred income taxes | 308.84 Thousand | -713.96 Thousand | 809.06 Thousand | 1.85 Million | -821.67 Thousand | -1.95 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 30.57 Million | 17.91 Million | 2.21 Million | 59 Million | 9.76 Million | 20.26 Million |
| Other non-cash items | 2.46 Million | 15.47 Million | 12.22 Million | -4.83 Million | 12.44 Million | 15.82 Million |
| Investing Cash Flow | -8.49 Million | -8.47 Million | -9.18 Million | -7.95 Million | -15.14 Million | -7.27 Million |
| Investments in PPE | -8.19 Million | -8.47 Million | -7.68 Million | -8.69 Million | -15.19 Million | -6.07 Million |
| Acquisitions | - | - | 318 Thousand | -230 Thousand | 52.57 Thousand | - |
| Investment purchases | -300 Thousand | - | -318 Thousand | - | - | -24.5 Million |
| Sales/Maturities of investments | - | - | 2.86 | - | - | 23.29 Million |
| Other Investing Activities | -300 Thousand | - | -1.49 Million | 978.24 Thousand | -15.19 Million | 10.63 Thousand |
| Financing Cash Flow | -5.61 Million | -6.57 Million | -7.7 Million | -90.5 Million | -29.53 Million | -16.7 Million |
| Debt repayment | -4.86 Million | -16 Million | -16 Million | -16.01 Million | -70.03 Million | -50 Million |
| Dividends payments | -766.27 Thousand | -717.47 Thousand | -703.93 Thousand | -540.89 Thousand | -3.5 Million | -2.69 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.84 Million | 10.14 Million | 9 Million | -73.94 Million | 44 Million | 35.98 Million |
| Accounts receivables | 38.86 Million | -925.23 Thousand | -16.03 Million | -17.54 Million | -51.31 Million | -18.86 Million |
| Accounts payables | 6.94 Million | 2.58 Million | 8.97 Million | -35.02 Million | 37.93 Million | 40.79 Million |
| Inventory | -15.54 Million | 16.97 Million | 8.46 Million | 109.72 Million | 24.11 Million | 281.54 Thousand |
| Other working capital | 7.24 Million | -713.96 Thousand | 809.06 Thousand | 1.85 Million | -969.05 Thousand | 19.98 Million |
| Cash at beginning of period | 27.68 Million | 37.86 Million | 54.59 Million | 53.08 Million | 39.42 Million | 40.72 Million |
| Cash at end of period | 15.21 Million | 27.68 Million | 37.86 Million | 54.59 Million | 53.08 Million | 39.42 Million |
| Capital Expenditure | -8.19 Million | -8.47 Million | -7.68 Million | -8.69 Million | -15.19 Million | -6.07 Million |
| Effect of forex changes on cash | 8668.28 | - | 0.35 | -268.7 Thousand | -309.12 Thousand | 111.22 Thousand |
| Net cash flow / Change in cash | -12.46 Million | -10.18 Million | -16.72 Million | 1.51 Million | 13.65 Million | -1.29 Million |
| Free Cash Flow | -6.56 Million | -3.6 Million | -7.53 Million | 91.53 Million | 43.43 Million | 16.49 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -8.09 Million | -2.96 Million | -80.41 Million | -31.95 Million | -5.54 Million |
| Depreciation & Amortization | - | 5.39 Million | 5.39 Million | 24.6 Million | 24.6 Million | -11.43 Million |
| Deferred income taxes | - | - | - | 308.84 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -15.65 Million | - | 30.57 Million | 23.32 Million | -2.71 Million |
| Other non-cash items | - | 7.99 Million | 8.38 Million | 2.46 Million | -14.88 Million | 19.41 Million |
| Investing Cash Flow | - | - | -2.1 Million | -8.49 Million | -6.7 Million | -339.76 Thousand |
| Investments in PPE | - | - | -2.1 Million | -8.19 Million | -6.7 Million | -339.76 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -300 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -300 Thousand | - | - |
| Financing Cash Flow | -869.49 Thousand | 189.1 Thousand | -5.84 Million | -5.61 Million | 666.51 Thousand | -513.92 Thousand |
| Debt repayment | - | -535.35 Thousand | - | -4.86 Million | - | - |
| Dividends payments | -138.58 Thousand | -175.48 Thousand | -190.59 Thousand | -766.27 Thousand | -192.12 Thousand | -186.62 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -730.91 Thousand | 899.94 Thousand | -5.65 Million | -4.84 Million | 858.63 Thousand | -327.3 Thousand |
| Accounts receivables | - | -14.42 Million | - | 38.86 Million | 38.86 Million | -15.34 Million |
| Accounts payables | - | - | - | 6.94 Million | - | - |
| Inventory | - | -1.22 Million | - | -15.54 Million | -15.54 Million | 12.63 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 11.03 Million | 12.69 Million | 15.21 Million | 27.68 Million | 20.21 Million | 21.37 Million |
| Cash at end of period | 10.97 Million | 11.03 Million | 12.69 Million | 15.21 Million | 15.21 Million | 20.21 Million |
| Capital Expenditure | - | - | -2.1 Million | -8.19 Million | -6.7 Million | -339.76 Thousand |
| Effect of forex changes on cash | -3008.46 | -65.83 Thousand | 19.51 Thousand | 8668.28 | -45.14 Thousand | -40.47 Thousand |
| Net cash flow / Change in cash | -66.83 Thousand | -1.65 Million | -2.51 Million | -12.46 Million | -4.99 Million | -1.16 Million |
| Free Cash Flow | - | -5.49 Million | 3.3 Million | -6.56 Million | -5.61 Million | -609.46 Thousand |
PVH
300791
NPR
GVS
0EWR
300815